[ad_1] 2 December 2020 Horizon Discovery Group plc, a global leader in applying gene editing and gene modulation to cell line engineering, today announced that it has granted two commercial licenses for its cGMP-compliant CHOSOURCE ™ platform to Sanyou Biopharmaceuticals Co., Ltd., a leading biotechnology company focused on the research, …
Read More »Targeting TAAR5 may provide a new treatment opportunity for neurodegenerative disorders
[ad_1] Reviewed by Emily Henderson, B.Sc.November 11, 2020 St Petersburg University researchers, led by Professor Raul R. Gainetdinov, director of the Translational Biomedicine Institute and Academic Supervisor of St Petersburg University Hospital, have found a new role for the recently discovered neurotransmitter system that uses the trace amine associated receptor …
Read More »